Skip to main content
Clinical Trials/NCT03148587
NCT03148587CompletedNot Applicable

Medication Abortion Self-Confirmation (MASC): Comparison of Two Home Pregnancy Tests as an Alternative to Office Follow-up

Stanford University1 site in 1 country88 target enrollmentStarted: May 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Locations
1
Primary Endpoint
Correct interpretation of pregnancy test

Study Overview

Brief Summary

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, without routine provider contact.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Gestational age of less than or equal to 63 days
  • •English speaking
  • •Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
  • •In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form

Exclusion Criteria

  • •Allergy to mifepristone and/or misoprostol
  • •Non-english speaking
  • •Inability to access internet

Arms & Interventions

Multi-level pregnancy test (MLPT)

Experimental

Patients randomized to multi-level pregnancy test (MLPT) arm will receive MLPTs to perform at home one and two weeks after taking mifepristone. They will be asked to interpret the results of the MLPT as it relates to their pregnancy termination status.

Intervention: Self-assessment: MLPT (Behavioral)

Low sensitivity pregnancy test (LSPT)

Experimental

Patients randomized to low sensitivity pregnancy test (LSPT) arm will receive LSPTs to perform at home at one and two weeks after taking mifepristone. They will be asked to interpret the results of the LSPT as it relates to their pregnancy termination status.

Intervention: Self-assessment: LSPT (Behavioral)

Outcomes

Primary Outcomes

Correct interpretation of pregnancy test

Time Frame: 4 weeks after taking medication abortion medication, mifepristone

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials